Quipt Home Medical Is Maintained at Buy by Canaccord Genuity
Quipt Home Medical Is Maintained at Buy by Canaccord Genuity
Express News | Canaccord Genuity Maintains Buy on Quipt Home Medical, Lowers Price Target to $8
Quipt Home Medical Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/17/2024 150.78% Canaccord Genuity $9 → $8 Maintains Buy 02/16/2024 213.48% Raymond James $10 → $10 Down
Express News | Quipt Home Medical Corp : Raymond James Cuts to Underperform From Market Perform; Cuts Target Price to $2.50 From $10
Express News | Quipt Home Medical Corp : Stifel Cuts Target Price to C$9.50 From C$10.50
Express News | Quipt Home Medical Corp : Canaccord Genuity Cuts Target Price to $8 From $9
Earnings Call Summary | Quipt Home Medical(QIPT.US) Q2 2024 Earnings Conference
The following is a summary of the Quipt Home Medical Corp. (QIPT) Q2 2024 Earnings Call Transcript:Financial Performance:Quipt Home Medical Corp reported Q2 revenues of $64 million, a 10% year-over-ye
Quipt Home Medical Corp. (QIPT) Q2 2024 Earnings Call Transcript
Quipt Home Medical Corp. (NASDAQ:QIPT) Q2 2024 Earnings Conference Call May 16, 2024 10:00 AM ET
Quipt Home Medical Shares Drop After Quarterly Loss Widens
By Robb M. Stewart Quipt Home Medical's shares fell sharply after the home medical equipment provider's loss unexpectedly widened in the latest quarter as the company was buffeted by a number of chal
Quipt Home Medical Reports Solid Growth in Q2
Quipt Home Medical Q2 2024 GAAP EPS $(0.03) Misses $0.01 Estimate, Sales $64.000M Miss $65.590M Estimate
Quipt Home Medical (NASDAQ:QIPT) reported quarterly losses of $(0.03) per share which missed the analyst consensus estimate of $0.01 by 400 percent. This is a 50 percent decrease over losses of $(0.02
Quipt Home Medical 2Q Loss/Shr 3c >QIPT.T
Quipt Home Medical 2Q Loss/Shr 3c >QIPT.T
Express News | Quipt Home Medical Q2 Revenue Growth 10%
Express News | Quipt Home Medical Q2 Adjusted Ebitda USD 14.9 Million
Express News | Quipt Home Medical Q2 Adjusted Ebitda Margin 23.3%
Express News | Quipt Home Medical Q2 Revenue USD 64 Million
Quipt Home Medical Reports Second Quarter Fiscal 2024 Financial Results Posting Revenue Growth of 10% and Adjusted EBITDA Growth of 14%
Quipt Home Medical Corp.(NASDAQ: QIPT; TSX: QIPT) today announced its second quarter fiscal 2024 financial results and operational highlights.
Notable Earnings After Wednesday's Close
Quipt Home Medical Readies for Growth With New Shelf Prospectus
Quipt Home Medical Expands Financial Horizons
No Data